Uncover the right answers with our oncohematology solutions
Take blood cancer care and clinical research to the next level
Blood cancer is an overarching term for cancers affecting the blood, bone marrow and lymphatic system. Other terms for blood cancer are hematological cancer and hematological malignancies. Blood cancer typically starts in the bone marrow, where blood is produced.
There are over 100 different types of blood cancer, each involving different key genes. This makes it impossible to have a single technology solution or approach to blood cancer care. But by closely examining the role of various signaling pathways and targeting specific steps in those pathways, we can identify specific molecular markers for each blood cancer type.
Discover molecular signatures
Comprehensive blood cancer solutions
Hematological malignancies vary widely due to wide biologic and genetic heterogeneity. Identifying specific, relevant molecular markers is crucial to advancing precision medicine and molecular research for blood cancer. However, data overload, multiple complex workflows from different vendors, and ever-evolving needs can pose challenges.
With our comprehensive Sample to Insight solutions, you only need one partner to help you overcome these issues and support your path to oncohematology advancements.
The power of having one oncohematology partner
We support your clinical blood cancer care and molecular research with a comprehensive assay, platform and service portfolio. In addition, we have broad expertise in IVD development and global regulatory and commercialization capabilities – making us the trusted partner for your blood cancer companion diagnostics.